Mirum Pharmaceuticals COO Sells Shares as Company Posts Strong Sales and Raises Guidance
Peter Radovich, president and COO of Mirum Pharmaceuticals (MIRM), sold 2,631 shares on February 2, 2026, to satisfy tax withholding tied to vesting restricted stock units. The transaction left him with a direct ownership of 20,655 shares. Separately, Mirum reported preliminary unaudited net product sales for 2025 of about $520 million, provided 20…